Virupaksha Organics Ltd. has emerged as a leader in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs). Founded in 2003, the company has built a reputation for innovation, quality, and sustainability. Under the dynamic leadership of Mr. Chandra Mouliswar Reddy Gangavaram, Virupaksha has grown its operations significantly, with state-of-the-art manufacturing facilities in Telangana, India.
The company’s facilities in Kazipally and Pashamylaram are certified by international and national regulatory bodies, including ISO 9001, ISO 14001, ISO 45001, ISO 50001, and GMP standards, ensuring that Virupaksha meets the highest levels of quality and safety in its production processes. These certifications highlight the company’s commitment to environmental sustainability, occupational safety, and best industry practices.
Virupaksha Organics is committed to excellence, innovation, and customer satisfaction, with a focus on developing sustainable solutions for the pharmaceutical industry. The company’s products are trusted by major pharmaceutical firms globally, as it continues to make strides towards becoming a research-driven organization. With a forward-thinking management team and a clear vision for the future, Virupaksha Organics is poised for rapid growth and continues to play a key role in advancing global healthcare.
As part of its corporate social responsibility (CSR), Virupaksha has initiated numerous welfare programs aimed at uplifting local communities and supporting environmental conservation, reinforcing its reputation as a responsible corporate citizen.
With continuous advancements and strategic partnerships, Virupaksha Organics Ltd. is well-positioned to expand its global footprint and contribute to the evolving pharmaceutical landscape.
Other Latest News
- <![CDATA[Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus]]> Dermatology Times LEO Pharma recently announced that it has initiated a phase 3 clinical program evaluating delgocitinib cream (Anzupgo) for the treatment of lichen sclerosus (LS), marking a significant development in a disease area with substantial unmet therapeutic need. …
- Walking the pharma supply chain tightrope requires more than precision Pharmaceutical Technology Between 2023 and 2025, hundreds of thousands of Type 2 diabetes patients were unable to access semaglutide due to off-label prescriptions for the drugs in individuals seeking weight loss. The GLP-1RA shortage exposed major fragilities in drug manufacturing …
- India News | Madhya Pradesh Engages Maldives, ReNew Power, Sandoz and NVIDIA to Explore Collaboration Across Key Sectors Latestly Bhopal (Madhya Pradesh) [India], January 21 (ANI): The Government of Madhya Pradesh on held a series of meetings with international and corporate delegations to explore collaboration opportunities across tourism, renewable energy, pharmaceuticals and …
- Moderna cancer vaccine holds up; IO Biotech considers a sale BioPharma Dive Today, a brief rundown of news from Moderna and IO Biotech, as well as updates from Insilico Medicine, Think Bioscience and Novavax that you may have missed. A regimen involving Moderna’s personalized cancer vaccine intismeran autogene and Merck & Co.’ …
- <![CDATA[Blujepa From GSK for Uncomplicated Urogenital Gonorrhea]]> Pharmacy Times The FDA recently approved gepotidacin (Blujepa; GSK) as an oral treatment for uncomplicated urogenital gonorrhea caused by susceptible strains of Neisseria gonorrhoeae in adults and pediatric patients aged 12 years and older weighing at least 45 kg.1 …
- Antihistamine Drugs Market | Global Forecast 2026-2032 | Revenues to Grow by $1.41 Billion - ResearchAndMarkets.com Voice of Alexandria - Minnesota DUBLIN--(BUSINESS WIRE)--Jan 21, 2026-- The "Antihistamine Drugs Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Antihistamine Drugs Market, experiencing substantial growth, expanded from USD 1.95 …
- When America Starts to Feel Like a Risky Asset Market Screener For a long time, the global economy has rested on a simple assumption: when things get messy, America is the place investors run to, not away from. This week, that assumption started to wobble. One year and one day into Donald Trump's second term, …
- High Pressure, Hidden Pain: Media Expands Mental Health Coverage During Peak Risk EIN Presswire January marks one of the highest-risk months for suicide; this initiative confronts the hidden mental health toll on high-performing individuals and athletes. ROCHESTER, NY, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- Fox Sports Radio …
- Roy Castle lung cancer charity slams decision to deny Scots patients life-saving drug on the NHS Scottish Daily Express Lung cancer is the most common cancer in Scotland with approximately 5,300 new cases diagnosed every year(Image: Getty) One of the UK's leading cancer charities has criticised Scotland's medicines watchdog after a groundbreaking new treatment was …
- A changing playing field: Observations of the 2026 JP Morgan Healthcare Conference from a European perspective European Biotechnology The answer, it turns out, depends on where you’re standing and increasingly, on how you position yourself between three competing poles of innovation. A more level field? “My impression is things are a little bit more quiet this year than in the past years …
- Ryan Murphy’s offensive new TV show is nearly unwatchable Metro To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Just months after All’s Fair was dubbed a bin fire not worth the metaphorical celluloid it had been committed to, uber-producer Ryan Murphy is …
- DIA Launches ASCENT Platform and LIFT Biotech & Startup Program to Accelerate Emerging Innovation Daily News-Record - Virginia WASHINGTON, Jan. 21, 2026 /PRNewswire/ -- The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support early-stage biotechnology drug development innovation, along with its inaugural …
- READY, FIRE, AIM: Quitting Drugs Pagosa Daily Post - Colorado And I’m not the only one quitting drugs. According to reporter Paula Span, writing in KFF Health News last week, older Americans are quitting drugs in droves. In droves. She put that idea in her article headline, so we didn’t miss it. Older Americans Quit …
- SBI TOP recovering after two days in the red STA Ljubljana, 21 January - The SBI TOP index of blue chips gained 0.34% in mixed trading after two consecutive days of loses to close at 2,667.14 points on Wednesday, still well below the 2,700-point mark it crossed earlier this month. Brokers concluded deals …
- Pomegranate Juice Reverses Heart Disease: The Natural Cure Big Pharma Fears Natural News Introduction: Nature's Answer to a Man-Made Epidemic Heart disease remains the leading cause of death globally, a grim testament to the catastrophic failure of a pharmaceutical-driven medical system that profits from sickness, not healing. While …
- Exclusive: Republican Michele Tafoya Enters Minnesota Senate Race to End 'Craziness and Corruption' Breitbart Michele Tafoya made a name for herself roaming stadium sidelines, but now she is ready to call the political plays. The renowned sports broadcaster is running in the Republican primary to represent Minnesota in the U.S. Senate, she announced Wednesday. …
- <![CDATA[Pharma Pulse: Industry Backlash, GSK’s $2.2B Immunology Bet, and the Future of Wearables]]> Pharmaceutical Commerce Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines. First, …
- ProRx Pharma Redefines Hormone Therapy with Needle-Free Oral Testosterone Option WFMZ - Pennsylvania Liquid Delivery System Helps Telemedicine Providers Deliver Safe, Effective TRT at Scale EXTON, Pa., Jan. 21, 2026 /PRNewswire/ -- ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced the commercial availability …
- AstraZeneca buys remaining China rights to GPC3 armored CAR-T therapy from AbelZeta Pharma for $630 M Biospectrum Asia AstraZeneca buys remaining China rights to GPC3 armored CAR-T therapy from AbelZeta Pharma for $630 M January 21, 2026 | Wednesday | News AstraZeneca owns the development, manufacturing and commercialisation rights to C-CAR031 outside of China image credit …
- Big-Pharma Partner Harbour BioMed Boosts Stake In Spruce Biosciences Benzinga Hong Kong-based Harbour BioMed on Sunday exercised its warrant to acquire the common stock in Spruce Biosciences Inc. (NASDAQ:SPRB). Following this transaction, Harbour BioMed holds approximately 3.8% of the total outstanding shares of Spruce and …
- Algeria To Invest In Agricultural Mechanization MENAFN (MENAFN- Brazil-Arab News Agency (ANBA)) São Paulo – Algeria's Minister of Agriculture, Rural Development, and Fisheries, Yacine El-Mahdi Oualid, said on Tuesday (20) in Algiers that the country will adopt measures this year to increase agricultural …
- Rising Stars: Regeneron’s Catie Matthews on updating marketing strategy to meet the AI boom Fierce Pharma Know a standout early-career pharma marketing pro? Submit your nominations for future "Rising Stars" honorees here. After earning her undergraduate degree in chemical engineering at Princeton, Catie Matthews, Ph.D., followed it with an MBA and a …
- JPM26 Recap, Novo’s Oral Wegovy Soars as Lilly’s Orforglipron Is Delayed, IPOs Return BioSpace > Listen on Spotify > Listen on Apple Products > Listen on Amazon Music > Listen on iHeart The 2026 J.P. Morgan Healthcare Conference concluded last week without a big M&A deal. But the meeting was anything but boring, with President Donald …
- Business News | BigBloc Construction Ltd Reports Revenue from Operations of Rs. 72.81 Crore in Q3FY26, Rise of 28.1% Y-o-Y Latestly PNN Surat (Gujarat) [India], January 21: BigBloc Construction Limited, one of the largest manufacturers of Aerated Autoclaved Concrete (AAC) Blocks, Bricks and ALC Panels in India has reported a consolidated revenue from operations of Rs. 72.81 crore …
- Five things for pharma marketers to know for Wednesday, January 21, 2025 Medical Marketing and Media Bristol Myers Squibb is partnering with Microsoft to use the tech company’s AI-driven radiology platform for early lung cancer detection. BMS said it will incorporate FDA-approved radiology AI algorithms through Microsoft’s platform, which is used in U.S. …
- Free-for-All in Davos Market Screener One year and one day after Donald Trump was sworn in for his second term, the world finds itself in a state of tension unseen for decades. The sharp deterioration of EU/US relations is unsettling the markets, which are now also eyeing political and …
- 54th Statehood day celebrations for Manipur, Meghalaya, and Tripura highlight northeast India’s historic journey News9 Live Events News India commemorates a defining moment in its democratic history as three northeastern states mark another year of statehood. The day reflects identity, unity, and progress. Revisit the legacy and understand its lasting national importance. India …
- Unmanned Combat Aerial Vehicle Market Size to Reach USD 47.78 Billion by 2035, Growing at 11.72% CAGR EIN Presswire Ottawa, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The primary driver of the unmanned combat aerial vehicle (UCAV) market is the rapid increase in global defense spending focused on reducing human risk in high-threat missions, coupled with rising demand for …
- Will the stock market crash in 2026? What the experts really think (and how investors can prepare) The Motley Fool UK Sensationalist news outlets love to jump on any opportunity to sow fear about a potential stock market crash. But far from the doom and gloom crowd, real market experts expect a rather more rational, boring outcome. Let’s see what the most prominent voices …
- ASX slides as Wall Street sells and gold surges Townsville Bulletin ASX slides again, down 0.37% Eight of 11 sectors lower, with 112/200 stocks falling Materials surges on gold price once again Materials pumps higher on fresh gold peak The materials sector has truly become the engine room of the ASX in recent months, …
- Business News | Bond Market Volatility Drags Stocks; Nifty Falls 0.36%, Sensex Down 0.47% at Opening Latestly Mumbai (Maharashtra) [India], January 21 (ANI): The domestic stock markets continued their weak trend on Wednesday, with benchmark indices opening in the red amid subdued global cues and rising risk aversion. The NIFTY 50 index opened at 25,141, down by 91 …
- Business News | India-EU FTA May Face Hurdles from Non-tariff Barriers Like CBAM: Jefferies Latestly New Delhi [India], January 21 (ANI): While India and the European Union move closer to finalising a long-pending Free Trade Agreement (FTA), concerns remain for India on non-tariff barriers, particularly the upcoming Carbon Border Adjustment Mechanism ( …
- Dalal Street Sees Red, Sensex Inches Closer To 82k, Nifty Remains Volatile ABP Live The Indian stock markets weren’t able to shake off the negative sentiment prevalent in equities on Wednesday morning. The BSE Sensex started the day near 82k, crashing a little over 100 points, while the NSE Nifty50 touched 25,200, taking a hit of 25 …
- Markets Open Lower Over Weak Global Cues, FII Selling; Sensex Down 168 Points Zee News Mumbai: The Indian benchmark indices continued their losses on Wednesday, tracking persistent global risk-off sentiment, continued foreign fund outflows and mixed earnings cues. As of 9.30 am, the Sensex lost 168 points, or 0.20 per cent to reach 82,012 …
- Biotech Stocks Skyrocket on Game-Changing News Raging Bull - New Hampshire Whoa, folks, hold onto your hats because today’s market is on fire with some massive movers! We’re talking about stocks that are shooting up like rockets, especially in the biotech space. As of this writing, these bad boys are leading the pack with eye- …
- I Visited Paris’ Skincare Mecca—These Are the 10 Products That Came Home With Me Marie Claire U.S. Share Share this article Follow us Add us as a preferred source on Google Excuse me while I mourn the fact that I am not still in Paris right now. I spent four days this past week galavanting around my favorite city, eating copious amounts of cheese and …
- Scientists discover powerful compounds in COFFEE that regulate blood sugar Natural News Researchers identified three new compounds (caffaldehydes A, B and C) in roasted coffee beans that slow carbohydrate digestion more effectively than the diabetes drug acarbose. These compounds inhibit alpha-glucosidase, the enzyme that breaks down carbs …
- Supreme Court Poised to Grant Chemical Warfare Immunity: How Glyphosate Legal Shield Would Poison American Justice Natural News Supreme Court Poised to Grant Chemical Warfare Immunity: How Glyphosate Legal Shield Would Poison American Justice Introduction: The Supreme Court’s Glyphosate Gamble: Corporate Immunity Over Human Life The U.S. Supreme Court has stepped onto a dangerous …
- Market Open: Wall Street’s back for WK4, and with it comes chaotic (down) day | Jan 21 The Market Herald Join our daily newsletter At The Bell to receive exclusive market insights ASX today − Losses are gathering steam this morning, with U.S. trading starting a day later thanks to Wall Street’s Monday holiday, and it’s sending our Australian shares towards a …
- <![CDATA[New Study Says No Link Between Tylenol and Autism: Report]]> Pharmaceutical Executive A new study suggests that there is no link between Tylenol and autism. More specifically, the research shows that women taking acetaminophen during pregnancy are most likely increasing the risk of neurodevelopmental issues. Up until last year, this was a …
- Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases treatment WFMZ - Pennsylvania Insilico Medicine and Hygtia Therapeutics, an incubatee of Shenzhen Pengfu Fund of Fosun Health Capital and Fosun Pharma, have entered into an exclusive license and co-development collaboration to advance ISM8969 worldwide. Under the agreement, both …
- The Inevitable Tribal Collision: How Proxy Uprising, Constitutional Power, and America’s Coming Civil War Intersect Natural News The Inevitable Tribal Collision: How Proxy Uprising, Constitutional Power, and America’s Coming Civil War Intersect Introduction: The Theater Unfolds The stage is set. In a nation fracturing along ideological fault lines, a recent report from Infowars.com …
- <![CDATA[Pharma, OTC Supplement Are Markets Expected to Grow Billions Come 2032]]> Drug Topics Across the world, the OTC supplements and pharma markets are expected to reach $565.76 billion by the year 2032, according to a news release from DataM Intelligence 4 Market Research.1 At a compound annual growth rate of 6.7%, this projection represents a …
- <![CDATA[FDA Grants Orphan Drug Designation to LP-284 for Soft Tissue Sarcoma]]> Cure Today The U.S. Food and Drug Administration (FDA) granted orphan drug designation to LP-284, an investigational treatment developed by Lantern Pharma, for patients with soft tissue sarcomas, according to a news release from the company. The designation applies …
- Local Notes: Ballyglass FC to launch 50th-anniversary book Western People Ballyglass Football Club's 50th-anniversary book will be launched tomorrow night, December 31st, commencing at 8pm int the local centre. It contains more than 300 pages packed with unforgettable moments, stories, photos, and the rich history of …
- <![CDATA[ten23 health and BD Team Up to Scale Wearable Injectors for High-Volume Subcutaneous Drug Delivery]]> Pharmaceutical Commerce ten23 health, a Swiss contract development and manufacturing organization (CDMO), is collaborating with BD (Becton, Dickinson and Company), to assist with the commercialization of its wearable injectable, BD Libertas.1 The partnership is expected to …
- National Psoriasis Foundation adopts new disease severity definition Healio News January 20, 2026 2 min read Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: New position …
- RAPT Therapeutics Jumps to Deal Level as GSK Acquisition Resets the Valuation Investing RAPT Therapeutics stock surged an extraordinary 64% on January 20, 2026, following the announcement that pharmaceutical giant GSK will acquire the immunology-focused biotech company for $2.2 billion. The all-cash deal values RAPT at $58 per share, …
- Tanabe Pharma’s dersimelagon hits success in Phase III EPP and XLP trial Clinical Trials Arena Tanabe Pharma America’s oral melanocortin-1 receptor (MC1R) agonist has met the primary endpoint in a Phase III trial in patients with erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP). The INSPIRE study (NCT06144840) of dersimelagon …
- Artemisinin Combination Therapy Market to Grow by $194 Million During 2026-2032 - ResearchAndMarkets.com Voice of Alexandria - Minnesota DUBLIN--(BUSINESS WIRE)--Jan 20, 2026-- The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artemisinin Combination Therapy (ACT) market exemplifies dynamic growth …